Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Vilex reported engagement with 104 surgeons and other clinicians in the states MedaRep covers, worth $627K in consulting, speaking, meals and travel for its device products, the most in Tennessee ($114K to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Tennessee ($114K, 2 engaged), Ohio ($92K, 10 engaged), Florida ($70K, 3 engaged), Kentucky ($59K, 10 engaged), Arkansas ($40K, 4 engaged).
In the last ten years FDA made 15 decisions for Vilex (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2023 (4). The latest was on 2026-04-17.
| Redemption Duo Hindfoot Nail System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Vilex.